Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma

Radiotherapy and Oncology

Volumn 50, Issue 1, 1999, Pages 33-38

  Mitchell, Gillian ^a   Huddart, Robert ^a   Harmer, Clive ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Accelerated radiotherapy; Anaplastic thyroid carcinoma; Phase II evaluation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DESQUAMATION; DOSE CALCULATION; DYSPHAGIA; ERYTHEMA; ESOPHAGITIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; THYROID CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DEGLUTITION DISORDERS; DISEASE PROGRESSION; ESOPHAGITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SURVIVAL RATE; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 0033045963     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00102-9     Document Type: Article

References (27)

1. Bourhis J., Fortin A., Dupuis O. Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;747-752.
2. Dische S., Saunders M.I., Barrett A., Harvey A., Gibson D., Parmar M.A. Randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 44:1997;123-136.
3. Fowler J.F. Potential for increasing the differential response between tumours and normal tissues: can proliferation rate be used? Int. J. Radiat. Oncol. Biol. Phys. 12:1986;641-645.
4. Harmer CL. Multidisciplinary management of thyroid neoplasms. In: Preece PE, Rosin RD, Mann AGD, editors. Head and neck oncology for the general surgeon. London: W.B. Saunders, 1991:55-90.
5. Harmer CL. Thyroid cancer. In: Horwich A, editor. Oncology: a multidisciplinary textbook. London: Chapman and Hall, 1995:565-584.
6. Harmer CL, Bidmead M, Shepherd S, Sharpe A, Vini L. Radiotherapy planning techniques for thyroid cancer. In press.
7. Hoskin P.J., Harmer C.L. Chemotherapy for thyroid cancer. Radiother. Oncol. 10:1987;187-194.
8. Huddart R.A., Hoskin P., Rhys-Evans P., Harmer C.L. High grade thyroid cancer treated by accelerated radiotherapy. Clin. Oncol. 5:1993;329.
9. Jereb B., Sternsward J., Lowhagen T. Anaplastic giant-cell carcinoma of the thyroid. A study of treatment and prognosis. Cancer. 35:1975;1293-1295.
10. Junor E.J., Paul J., Reed N.S. Dyspnoea: a major prognostic indicator in anaplastic thyroid carcinoma. Clin. Oncol. 3:1991;299.
11. Kim J.H., Leeper R.D. Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy. Cancer. 52:1983;954-957.
12. Levendag P.C., De Porre P.M.Z.R., van Putten W.L.J. Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;125-128.
13. Nel C.J.C., van Heerden J.A., Goellner J.R., et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin. Proc. 60:1985;51-58.
14. Nguyen T.D., Panis X., Froissart D., Legros M., Coninx P., Loirette M. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;23-25.
15. Schlumberger M., Parmentier C., Delisle M.-J., Couette J.-E., Droz J.-P., Sarrazin D. Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer. 67:1991;564-566.
16. Schoumacher P., Metz R., Bey P., Chesneau A.M. Anaplastic carcinoma of the thyroid gland. Br. J. Cancer. 13:1977;381-383.
17. Shimaoka K., Schoenfeld D.A., DeWys W.D., Creech R.H., DeConti R. A randomised trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer. 56:1985;2155-2160.
18. Simpson W.J. Anaplastic thyroid carcinoma: a new approach. Can. J. Surg. 23:1980;25-27.
19. Spires J.R., Schwartz M.R., Miller R.H. Anaplastic thyroid carcinoma. Arch. Otolaryngol. Head Neck Surg. 114:1988;40-44.
20. Tallroth E., Wallin G., Lundell G., Lowhagen T., Einhorn J. Multimodality treatment in anaplastic giant cell thyroid carcinoma. Cancer. 60:1987;1428-1431.
21. Thames H.D., Peters L.J., Withers H.R., Fletcher G.H. Accelerated fractionation: rationales for several treatments per day. Int. J. Radiat. Oncol. Biol. Phys. 9:1983;127-138.
22. Tubiana M. Repopulation in human tumours. A biological background for fractionation in radiotherapy. Acta Oncol. 27:1988;83-88.
23. Van Den Bogaert W, Horiot J-C, Van Der Schueren E. Radiotherapy with multiple fractions per day. In: Steel GG, Adams GE, Horwich A, editors. The biological basis of radiotherapy. Amsterdam: Elsevier, 1989:209-221.
24. Venkatesh Y.S.S., Ordonez N.G., Schultz P.N., Hickey R.C., Goepfert H., Samaan N.A. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases. Cancer. 66:1990;321-330.
25. Werner B., Abele J., Alveryd A., et al. Multimodal therapy in anaplastic giant cell thyroid carcinoma. World J. Surg. 8:1984;64-70.
26. Wong C.S., Van Dyk J., Simpson W.J. Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother. Oncol. 20:1991;3-9.
27. Yoshida A., Fukazawa M., Ushio H., Aiyoshi Y., Soeda S., Ito K. Study of cell kinetics in anaplastic thyroid carcinoma transplanted into nude mice. J. Surg. Oncol. 41:1989;1-4.